13F Holdings
中文EN

PETS PETMED EXPRESS INC

Retail-Drug Stores and Proprietary Stores · Nasdaq · SEC CIK 1040130 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-17.4%
TTM net income YoY50.6%
TTM EPS YoY51.1%
Revenue 3-yr CAGR-15.2%
Net income 3-yr CAGR—

Margins

Gross margin27.8%
Operating margin-18.0%
Net margin-17.0%
FCF margin-15.4%
EBITDA margin-12.3%

Returns

ROE-90.8%
ROA-34.1%
ROIC (approx.)-366.8%
Asset turnover2.01x

Leverage & solvency

Liabilities / assets71.6%
Debt / equity0.00x
Current ratio0.60x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.83x
Accruals ratio-5.6%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31FY20242024-03-31FY20232023-03-31FY20222022-03-31
Income statement
Revenue$179.02M$226.97M$274.10M$247.57M$272.28M
Cost of revenue—$157.84M$189.33M$171.07M$195.34M
Gross profit$50.22M$69.14M$84.77M$76.50M$76.94M
SG&A expense$50.73M$38.65M$55.25M$41.71M$31.11M
Operating income-$58.67M-$1.53M-$8.16M$6.05M$24.29M
Pretax income-$57.36M-$587,000-$6.27M$7.45M$24.18M
Income tax-$73,000$5.68M$1.19M$2.31M$5.47M
Net income-$57.29M-$6.27M-$7.46M$5.14M$18.72M
EBITDA-$49.29M$5.51M-$1.11M$9.60M$27.03M
EPS (basic)-2.74-0.30-0.370.250.93
EPS (diluted)-2.74-0.30-0.370.250.92
Dividends declared per share0.000.000.601.201.20
Weighted avg. shares (diluted)20.92M20.60M20.40M20.34M20.36M
Balance sheet
Cash & equivalents$21.41M$54.72M$55.30M$104.09M$111.08M
Receivables$1.91M$2.32M$3.28M$1.74M$1.91M
Inventory$13.61M$16.20M$28.56M——
Current assets$43.56M$78.87M$93.65M$130.43M$151.00M
PP&E, net$26.33M$28.86M$26.66M$26.18M$24.46M
Goodwill$0$26.66M$26.66M$0—
Intangibles$5.49M$8.05M$11.20M$860,000$860,000
Total assets$81.19M$148.70M$169.88M$167.48M$179.70M
Current liabilities$52.03M$62.77M$72.16M$57.51M$56.25M
Total liabilities$52.25M$63.57M$73.15M$57.51M$56.25M
Shareholders' equity$28.94M$85.13M$96.73M$109.97M$123.45M
Shares outstanding21.39M20.66M21.15M21.08M20.98M
Cash flow statement
Operating cash flow-$28.39M$4.72M$4.32M$27.80M$18.50M
Capital expenditure$4.62M$5.11M$4.51M$5.26M$1.75M
Free cash flow-$33.01M-$395,000-$194,000$22.54M$16.75M
Investing cash flow-$4.62M-$5.11M-$40.67M-$10.26M-$1.75M
Financing cash flow-$299,000-$181,000-$12.44M-$24.54M-$24.38M
Depreciation & amortization$9.39M$7.04M$7.06M$3.55M$2.74M
Stock-based compensation$1.36M-$6.59M$6.87M$6.62M$4.55M
Dividends paid$21,000$181,000$12.44M$24.54M$24.38M
Share buybacks————$0

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.